Longterm efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer's dementia

被引：0
|
作者：
Street, J [1 ]
Clark, W [1 ]
Juliar, B [1 ]
Feldman, P [1 ]
Kadam, D [1 ]
Breier, A [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2000年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P280
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [21] Behavioral and psychotic symptoms of dementia in the United States
    Wu, Chuang-Kuo
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 : S92 - S93
  • [22] Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms
    Ballard, C.
    Youakim, J. M.
    Coate, B.
    Stankovic, S.
    [J]. JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2019, 6 (01): : 27 - 33
  • [23] Acute mania and psychotic symptoms in bipolar patients: The efficacy of treatment with risperidone and olanzapine
    Basi, C
    Gambini, O
    Luoni, A
    Corbetta, A
    Scarone, S
    [J]. SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 143 - 143
  • [24] Pimavanserin in Alzheimer’s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms
    Clive Ballard
    J. M. Youakim
    B. Coate
    S. Stankovic
    [J]. The Journal of Prevention of Alzheimer's Disease, 2019, 6 : 27 - 33
  • [25] PSYCHOTIC SYMPTOMS IN PATIENTS WITH DEMENTIA
    BALLARD, C
    OYEBODE, F
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1995, 10 (09) : 743 - 752
  • [26] Psychotic symptoms in Parkinson's disease patients with dementia
    Naimark, D
    Jackson, E
    Rockwell, E
    Jeste, DV
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (03) : 296 - 299
  • [27] Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's dementia
    De Deyn, PP
    Carrasco, MM
    Deberdt, W
    Jeandel, C
    Hay, DP
    Feldman, PF
    Young, CA
    Lehman, DL
    Breier, A
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A57 - A57
  • [28] Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's dementia
    Hoffmann, VP
    DeDeyn, PP
    Carrasco, MM
    Deberdt, W
    Jeandel, C
    Hay, DP
    Feldman, PD
    Young, CA
    Lehman, DL
    Breier, A
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 337 - 337
  • [29] Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's dementia
    De Deyn, PP
    Carrasco, MM
    Deberdt, W
    Jeandel, C
    Hay, DP
    Feldman, PD
    Young, CA
    Lehman, DL
    Breier, A
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S345 - S345
  • [30] Pharmacological modulation of cognitive and behavioral symptoms in patients with dementia due to Alzheimer's disease
    de Oliveira, Fabricio Ferreira
    Bertolucci, Paulo Henrique Ferreira
    Chen, Elizabeth Suchi
    Smith, Marilia de Arruda Cardoso
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2014, 336 (1-2) : 103 - 108
12345